📰 ET Markets 🟢 BULLISH 🕒 02 Nov 2026, 06:45 AM IST

Sun Pharma’s specialty portfolio, Organon deal to drive growth

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Sun Pharma’s specialty portfolio, Organon deal to drive growth

📊

Market & Financial Impact: Sun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines. The company anticipates medium-term growth from therapies like Ilumya and ongoing innovative projects. Although profitability was affected by acquisition and litigation costs, the domestic market share increased to 8.6% from last year. R&D investments are expected to rise in the second half of FY27 as development accelerates.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

The company's domestic market share rose to 8.6% in the September 2026 quarter from 8.3% a year earlier.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

You can buy a walkie-talkie online. But can you legally use it?

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Sun Pharma’s specialty portfolio, Organon deal to drive growth

🔥 More Live Market Stories

[APOLLO] Updates - Apollo Micro Systems Limited

INSIGHT - Crypto blitzes midterms with US$176 million to support allies as it prepares for post-Trump era - Awani International

Sensex options volumes soar to record highs as oil boils

Stock Market LIVE: GIFT Nifty rises over 100 pts; Asia markets mixed; Brent crude drops 2%

Trading Plan: Can Nifty 50 surpass its October swing high, Bank Nifty rebound above 55,000?

Positive Breakout: These 6 stocks cross above their 200 DMAs